Questions with an asterisk require an answer.
#RAREis Global Advocate Grant
"*" indicates required fields
Select Your Language:
As part of our mission, we strive to improve the experience of living with a rare disease by providing support to many organizations that offer crucial programs and services for people living with rare diseases.
The #RAREis Global Advocate Grant was launched by Horizon Therapeutics in 2022 to support the rare disease community by providing financial assistance to global advocacy groups working to advance, educate and address the needs of the community.
This year, we made a $250,000 commitment to provide 50 one-time $5,000 grants to global rare disease advocacy organizations to support programs and disease education initiatives. Please complete the application below to submit your organization for a #RAREis Global Advocate Grant by 11:59 p.m. CT on March 31, 2023. Recipients will be announced in July.
To qualify for consideration, an organization must be considered a non-profit organization, focused on supporting the rare disease community outside of Horizon’s disease states, all funds will be used in the year received and no healthcare providers will be receiving benefit from this grant.